$0.9500
0.0384.17%
Ult. Agg.: Oct 23, 8:28 AM
Cocrystal Pharma (COCP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.17 | $-0.15 | $-0.18 | $-0.22 |
| Actual | $-0.23 | $-0.17 | $-0.17 | $-0.19 |
| Surprise | -35.3% | -13.3% | +5.56% | +13.6% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $105000 | $225000 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.17 | $-0.15 |
| Revenue | ||
| Consensus | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.23 | $-0.17 | -35.3 % |
| Q1 | May 15, 2026 | $-0.17 | $-0.15 | -13.3 % |
| Q4 | Mar 31, 2026 | $-0.17 | $-0.18 | 5.56 % |
| Q3 | Nov 14, 2025 | $-0.19 | $-0.22 | 13.6 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 14, 2023 | $0 | $270.00K | -100.0 % |
| Q1 | May 15, 2023 | $0 | $170.00K | -100.0 % |
| Q3 | Nov 14, 2022 | $0 | $80.00K | -100.0 % |